Table 1.
Population data.
| Variables | All Patients (n = 92) |
|---|---|
| Age (years) | 62.7 (±17.7) |
| Sex (M/F) | 60 (65.2%)/32 (34.8%) |
| BMI | 26 (±3.7) |
| eGFR (mL/min) | 68 (±23) |
| CKD Stage | 2 (1–3) |
| INR | 1.3 (±0.3) |
| aPTT (s) | 38.2 (±5.1) |
| PT (s) | 14.3 (±2.8) |
| D-Dimer (mg/L) | 1.2 (±0.7) |
| Fibrinogen (g/L) | 1.9 (±0.6) |
| Platelet count (No. ×103/μL) | 363 (±105.6) |
| Coagulopathy (no/yes) | 58 (63%)/34 (37%) |
| Hemoglobin (g/dL) | 7.7 (±0.7) |
| CT angiography execution | 80 (87%) |
| Bleeding on CT angiography | 77 (83.7%) |
Antiplatelet therapy
|
20 (21.7%) 10 (10.9%) 10 (10.9%) |
| Anticoagulant therapy | 62 (67.4%) |
| Antiplatelet AND anticoagulant therapy | 0 (0%) |
| Antiplatelet OR anticoagulant therapy | 82 (89.1%) |